Colon cancer is the third most common type of cancer in the world.

     Colorectal carcinoma, also called colon cancer, begins with an abnormal growth of cells in the colon or rectum. This leads to colon cancer or rectal cancer respectively. Doctors usually put these types of cancer in one category because they have many characteristics in common. In most cases, colon cancer arises from benign growths on the inner surface of the colon, called polyps. Over time, some polyps may mutate and transform into cancerous tissue. 

     The exact cause of the development of colon cancer is still not clear, but there are some risk factors that are associated with the disease. Having a family history of colorectal cancer or cancer of the ovaries, breast and uterus in women, as well as certain hereditary gene syndromes, previously detected polyps or inflammatory bowel disease, can increase the risk of developing colon cancer, especially in people who have lived with them for more than 10 years. 

     According to studies, one third of patients diagnosed with colorectal cancer are under the age of 55. Colon cancer affects women and men almost equally.  Colorectal carcinoma very often has no specific early symptoms until it is advanced. Therefore, regular screening helps detect the disease before symptoms develop, when colon cancer is most treatable. Screening may need to start at age 40 or even earlier if you have any risk factors. 

     Colon cancer prognosis and treatment largely depend on the stage at which the disease is diagnosed. Stages are graded on a scale from 0 (carcinoma in situ) to IV. In the earlier stages, the cancer is confined to the wall of the colon, while in stage IV it has spread to distant organs (metastasized). 

      When the disease is detected at an early stage, before it has spread, the 5-year survival rate exceeds 90%. Cancer is considered cured if it does not recur within 5 years. In the advanced stage, the survival rate is lower, but steadily increasing. What you need to know is that colorectal cancer is a curable disease, especially if it is diagnosed at an early stage. Depending on the case, surgery, chemotherapy, targeted therapy, immunotherapy, or radiation therapy may be used in combination or individually. 

Along with known cancer treatment methods such as surgery, chemotherapy and radiation therapy, Targeted Colon Cancer Therapy can also be used here. Unlike chemotherapy, which affects healthy cells along with cancerous tissues, targeted drugs attack only malignant cells and do not cause serious side effects. They are widely used in the treatment of colon cancer, especially in stage IV.

     According to some studies, when used together with conventional chemotherapy, they can increase effectiveness her 25 - 30%  Immunotherapy also has a place in the treatment of colon cancer. Immunopreparations are usually used at the end of treatment and last longer. Catraps is administered in the same way in different doses and at different intervals for 5 years or more to maintain the body's homeostasis. 

     The 5-year survival rate for these patients is 48.7%, taking into account that the majority of them underwent surgery and then underwent radiotherapy, and a smaller part also underwent chemotherapy for various indications. KATRAPS was administered after completion of these therapies and survival was reported from the start of KATRAPS treatment. More than half of patients with more than 5-year survival have been treated with us for more than 10 and even more than 20 years.